Pages that link to "Q36313997"
Jump to navigation
Jump to search
The following pages link to Non-high-density lipoprotein cholesterol: the forgotten therapeutic target (Q36313997):
Displaying 8 items.
- Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia (Q28076399) (← links)
- Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II). (Q31120863) (← links)
- Triglycerides and Cardiovascular Risk (Q33654016) (← links)
- Effectiveness of combined statin plus omega-3 fatty acid therapy for mixed dyslipidemia (Q34042886) (← links)
- Enhancement of a modified Mediterranean-style, low glycemic load diet with specific phytochemicals improves cardiometabolic risk factors in subjects with metabolic syndrome and hypercholesterolemia in a randomized trial (Q36986975) (← links)
- A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the “Back of the Line” as a therapy for dyslipidemia? (Q42752704) (← links)
- Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients. (Q51464453) (← links)
- Analysis of the Correlation between Non-high Density Lipoprotein Cholesterol and Coronary Heart Disease in Elderly Chinese (Q84361741) (← links)